Why I’d buy this hot growth stock over IQE plc

Why this growth stock attracts me more than IQE plc (LON: IQE) right now.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

I reckon the underlying growth story at NEX Group (LSE: NXG) is a good one, and recent weakness in the share price is giving us a good opportunity to research the stock as a potential ‘buy’.

The firm provides trading platforms, expertise and other services for global banks, asset managers, companies and others, and today’s interim results suggest ongoing growth potential. Revenue from continuing operations lifted 7% on a constant currency basis compared to a year ago and operating profit excluding one-off items held steady with a minor 1% decrease. However, underlying earnings per share came in 13% lower and the directors declared a much-reduced interim dividend of 3.5p per share, which compares to last year’s payment of 11.5p.

A progressive dividend policy

Looking forward from this lower dividend level, NEX has plans to deliver a progressive dividend policy, which it says will be set between 40% and 50% of post-tax trading profit. Growth opportunities and cost savings look set to keep earnings rising from here with the directors announcing that they’ve identified the potential for £40m in annual cost savings over the next three years. City analysts following the firm expect earnings to come in 11% higher for the full year to March 2018 and 34% up to March 2019.

Chief executive Michael Spencer reckons the firm has seen a transitional and transformational year.” He expects NEX to achieve compound annual revenue growth of 7% to 10% and operating margins of more than 40% for its NEX Optimisation and NEX Markets divisions by the 2019/20 full trading year.

A question of valuations

Meanwhile, today’s share price of around 586p throws up a forward price-to-earnings (P/E) ratio a little under 17 for the year to March 2019 and the forward dividend yield runs just over 2.8%. Those anticipated forward earnings should cover the payment more than twice.

I reckon the valuation looks reasonable and the firm could make a more comfortable hold than IQE (LSE: IQE), for example.

IQE’s successful placing of new shares raised £95m on 10 November at a price of 140p per share. I reckon that’s quite an achievement for a company that was trading at just 30p per share a year before that and it underlines the potential for growth that investors see in the firm’s business of manufacturing advanced wafer services for the semiconductor industry.

Ramping up capital investment

The directors want the extra money to ramp up capital expenditure aimed at scaling the business for “multiple high growth mass-market opportunities.”  The story has captured the imagination of many, and if we do end up seeing IQE’s products in mass-market smartphones and the like, we could witness profits multiplying many times down the road.

However, with the share price standing around 173p, the forward P/E rating for 2018 runs at 41, which seems high considering that City analysts predict growth in earnings of just 27% that year. It’s true that earnings could explode if mass-market adoption of IQE products happens, leaving the analysts scurrying to catch up. But equally, delays or disappointments could materialise to knock the share price down again. I think you need nerves of steel to hold IQE today, so I’d be more inclined to consider Nex Group as a potential investment.

 

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Kevin Godbold has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

 
 
 
 

More on Investing Articles

Investing Articles

Down 85%, but I’m backing this FTSE 250 stock to fly like the Rolls-Royce share price

The Rolls-Royce share price has flown to the stars and Harvey Jones thinks it's too late to buy. So he's…

Read more »

British flag, Big Ben, Houses of Parliament and British flag composition
Investing Articles

Is now the right time for me to buy revived FTSE national institution Marks and Spencer?

Marks and Spencer was once a revered FTSE 100 firm, but poor decisions led to its demotion in 2019. Now…

Read more »

Market Movers

Up 11% today, can this FTSE 250 stock finally get motoring?

Jon Smith explains why the Aston Martin share price has jumped this morning, but urges caution after he picks apart…

Read more »

Investing Articles

With £456m of net cash, FTSE 100 stock easyJet’s ready for take-off

Our writer's been positive on this FTSE 100 for some time, but these Q3 results and its growing cash pile…

Read more »

A senior woman sits up on the exam table at a doctors appointment. She is dressed casually in a blue sweater and has a smile on her face as she glances at the doctor. Her female doctor is wearing a white lab coat and seated in front of her as she takes notes on a tablet.
Investing Articles

Primary Health Properties: a FTSE 250 REIT with a 6% yield, a growing dividend, and a positive outlook

After its latest results show rental income growth, Stephen Wright's looking to buy a FTSE 250 REIT set to benefit…

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

How much passive income could I make for every £1,000 invested in Aviva shares?

Even a relatively small investment in Aviva shares could generate much greater passive income, particularly if the dividends are reinvested…

Read more »

Close-up of British bank notes
Investing Articles

I’m considering 100 shares in this FTSE 250 gem to aim for £300 a month in dividends

Mark Hartley outlines why a lesser-known banking stock from the FTSE 250's worth considering for an income portfolio in 2024.

Read more »

Investing Articles

History suggests these UK shares might soar if interest rates are cut in August

Some UK shares could rocket if interest rates fall from its 5.25% high next month. And there's one our writer…

Read more »